
Actinium-225 (Ac-225) Targeted Radionuclide Therapy Treatment Description: Actinium-225 targeted radionuclide therapy is an advanced form of nuclear medicine treatment that uses the radioactive isotope Actinium-225 to selectively target and destroy cancer cells. The treatment is generally administered through an intravenous injection and is designed to deliver highly localized radiation to tumor cells while minimizing exposure to surrounding healthy tissues. The treatment is typically considered for selected patients with advanced or metastatic cancers that express specific molecular targets, depending on the patient's diagnosis and eligibility. The Treatment Package Includes: Medical evaluation by a Nuclear Medicine specialist Review of the patient's medical history and previous treatment records Required laboratory and imaging examinations Actinium-225 targeted radionuclide therapy administration Nuclear Medicine specialist consultation and treatment planning Medical monitoring during and after the treatment Post-treatment medical evaluation and follow-up recommendations Important: Patient eligibility and the appropriate Actinium-225 treatment protocol are determined after evaluation of medical records, imaging, laboratory results, and the specific molecular target of the tumor.
Bookimed is an international medical tourism platform founded in 2014. We are made of people and for people — and that’s our core value. We cooperate with simply the best doctors & clinics and work hard every day to make people healthier and happier. Over 800,000 patients used the platform so far. Additionally to our primary activities, we collaborate with charity projects and create supportive communities. Our main office is in Kyiv, Ukraine, still, we’re online 24/7 wherever you are.
The information provided on the website is not a guide to action and should not be construed as medical advice or treatment recommendation, nor should it be considered a substitute for a visit to a doctor.